Technical420 Site Search

Two Nasdaq traded cannabis companies announced earnings during the last week. These companies, Insys Therapeutics (INSY) and GW Pharmaceuticals (GWPH), are focused on improving daily life for millions of people around the world by developing medicines derived from cannabis.Insys Therapeutics, Inc. (INSY)Insys Therapeutics, Inc. is commercial-stage specialty pharmaceutical company that…

The emergence of the cannabis industry has created a number of wealth building opportunities for investors. There are more 250 publicly traded cannabis companies, however, most of them will dissolve or shut down over the next two years. Today, we are going to discuss 5 companies that every investor should…

Every day there seems to be a new article about the medical benefits associated with marijuana. These benefits create an opportunity that cannabis cultivators are trying to capitalize on.  Once these growers find a strain that combats a certain illness, they try and patent it. From 1989 to 2013, the…

One of the most frequently asked questions I have received over the last year pertains to how an investor can diversify their portfolio of cannabis stocks. A year ago, I would have said that it is impossible to be diversified in an industry filled with non-reporting, unregulated, developmental companies.Today, the theory…

Insys Therapeutics, Inc. (NASDAQ: INSY) reported fourth quarter and year-end financial results. The market has reacted poorly to this announcement and the stock is trading in negative territory.Highlights from the fourth quarter include:Net revenue increased to $66.5 million versus $40.2 million in the fourth quarter of 2013.INSY generated $66.2 million in revenues…

Insys Therapeutics, Inc. (INSY) announced that the FDA granted the Fast Track designation to its CBD formulation for the treatment of Dravet’s syndrome. INSY’s new, DEA-inspected facility will allow the company to manufacture mass quantities of CBD for its research and commercial plans."Coupled with our candidate's orphan drug designation in…

Less than two weeks ago, Michael Berger, president of Technical420, hosted a panel of marijuana experts at the World Moneyshow in Orlando. The panel included experts that serve in a number of subsectors in the cannabis industry. The panelists were Stephen Schultz, the vice president of investor relations at GW Pharmaceutical (GWPH:…

Arizona might be the next state to legalize recreational marijuana. The state representative of Arizona, Mark Cardenas, recently started drafting a bill that would legalize recreational marijuana. He believes that the state needs to be proactive on the matter because it is easier to change a legislative bill than it…